Key Metrics
CiteScore 

2.9
H-Index 

17
SJR 

Q2Pharmacology

SNIP 

0.78
Recommended pre-submission checks
Powered by 

Topics Covered on PharmacoEconomics - Open
PharmacoEconomics - Open Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | SPRINGER INT PUBL AG |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 2790 | USD 3490 | GBP 2390 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in PharmacoEconomics - Open ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in PharmacoEconomics - Open
Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain.
- 1 Jul 2026
- PharmacoEconomics - open
Availability, Prices, and Affordability of Immune Checkpoint Inhibitors: A Cross-Sectional Study in Anhui Province, China.
- 29 Jun 2026
- PharmacoEconomics - open
Estimating the Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Portugal Using a Dynamic Transmission Model.
- 29 Jun 2026
- PharmacoEconomics - open
Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.
- 18 Jun 2026
- PharmacoEconomics - open
Health Utility Values Measured by EQ-5D in Breast Cancer From Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis Protocol.
- 10 Jun 2026
- PharmacoEconomics - open
Budget Impact Analysis of Vacuum-Assisted Excision Versus Surgical Excision for the Assessment of Breast Lesions of Uncertain Malignant Potential in Italy.
- 9 Jun 2026
- PharmacoEconomics - open
Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain.
- 1 Jul 2026
- PharmacoEconomics - open
Availability, Prices, and Affordability of Immune Checkpoint Inhibitors: A Cross-Sectional Study in Anhui Province, China.
- 29 Jun 2026
- PharmacoEconomics - open
Estimating the Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Portugal Using a Dynamic Transmission Model.
- 29 Jun 2026
- PharmacoEconomics - open
Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.
- 18 Jun 2026
- PharmacoEconomics - open
Health Utility Values Measured by EQ-5D in Breast Cancer From Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis Protocol.
- 10 Jun 2026
- PharmacoEconomics - open
Budget Impact Analysis of Vacuum-Assisted Excision Versus Surgical Excision for the Assessment of Breast Lesions of Uncertain Malignant Potential in Italy.
- 9 Jun 2026
- PharmacoEconomics - open